Journal article
Randomized phase II-III study of matrix metalloproteinase inhibitor (MMPI) BMS-275291 in combination with paclitaxel (P) and carboplatin (C) in advanced non-small cell lung cancer (NSCLC): NCIC-CTG BR.18
Authors
Leighl NB; Shepherd F; Paz-Ares L; Douillard J-Y; Peschel C; Arnold A; Tu D; Galbraith S; Hann K; Seymour L
Journal
Journal of Clinical Oncology, Vol. 22, No. 14_suppl, pp. 7038–7038
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
July 15, 2004
DOI
10.1200/jco.2004.22.14_suppl.7038
ISSN
0732-183X